<?xml version="1.0" encoding="UTF-8"?><rdf:RDF
    xmlns:vitro-public="http://vitro.mannlib.cornell.edu/ns/vitro/public#"
    xmlns:c4o="http://purl.org/spar/c4o/"
    xmlns:obo="http://purl.obolibrary.org/obo/"
    xmlns:ocrer="http://purl.org/net/OCRe/research.owl#"
    xmlns:owl2="http://www.w3.org/2006/12/owl2-xml#"
    xmlns:vivo="http://vivoweb.org/ontology/core#"
    xmlns:swrlb="http://www.w3.org/2003/11/swrlb#"
    xmlns:aka="http://vivoweb.org/ontology/aka#"
    xmlns:far="http://vitro.mannlib.cornell.edu/ns/reporting#"
    xmlns:ocresd="http://purl.org/net/OCRe/study_design.owl#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:aktp="http://www.aktors.org/ontology/portal#"
    xmlns:tamu="http://vivo.library.tamu.edu/ontology/TAMU#"
    xmlns:socsci="http://vivo.library.cornell.edu/ns/vivo/socsci/0.1#"
    xmlns:event="http://purl.org/NET/c4dm/event.owl#"
    xmlns:statistics="http://purl.org/net/OCRe/statistics.owl#"
    xmlns:sce="http://vivoweb.org/ontology/SchoolOfContinuingEducation#"
    xmlns:config="http://vitro.mannlib.cornell.edu/ns/vitro/ApplicationConfiguration#"
    xmlns:skos2="http://www.w3.org/2008/05/skos#"
    xmlns:vivoc="http://vivo.library.cornell.edu/ns/0.1#"
    xmlns:pubmed="http://vitro.mannlib.cornell.edu/ns/pubmed#"
    xmlns:mann="http://vivo.cornell.edu/ns/mannadditions/0.1#"
    xmlns:cce="http://vivoweb.org/ontology/cornell-cooperative-extension#"
    xmlns:owl="http://www.w3.org/2002/07/owl#"
    xmlns:fabio="http://purl.org/spar/fabio/"
    xmlns:swrl="http://www.w3.org/2003/11/swrl#"
    xmlns:hr="http://vivo.cornell.edu/ns/hr/0.9/hr.owl#"
    xmlns:pvs="http://vivoweb.org/ontology/provenance-support#"
    xmlns:wos="http://vivo.mannlib.cornell.edu/ns/ThomsonWOS/0.1#"
    xmlns:scirr="http://vivoweb.org/ontology/scientific-research-resource#"
    xmlns:cito="http://purl.org/spar/cito/"
    xmlns:stars="http://vitro.mannlib.cornell.edu/ns/cornell/stars/classes#"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:afn="http://jena.hpl.hp.com/ARQ/function#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:local="http://vivo.cornell.edu/ontology/local#"
    xmlns:study_protocol="http://purl.org/net/OCRe/study_protocol.owl#"
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:scires="http://vivoweb.org/ontology/scientific-research#"
    xmlns:ai="http://vivoweb.org/ontology/activity-insight#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
    xmlns:wcmc="http://weill.cornell.edu/vivo/ontology/wcmc#"
    xmlns:geo="http://aims.fao.org/aos/geopolitical.owl#"
    xmlns:app="http://eagle-i.org/ont/app/1.0/"
    xmlns:skos="http://www.w3.org/2004/02/skos/core#"
    xmlns:display="http://vitro.mannlib.cornell.edu/ontologies/display/1.1#"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:ospcu="http://vivoweb.org/ontology/cu-vivo-osp#"
    xmlns:vitro="http://vitro.mannlib.cornell.edu/ns/vitro/0.7#"
    xmlns:vann="http://purl.org/vocab/vann/"
    xmlns:vcard="http://www.w3.org/2006/vcard/ns#"
    xmlns:swvs="http://www.w3.org/2003/06/sw-vocab-status/ns#"
    xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" > 
  <rdf:Description rdf:about="http://purl.org/net/OCRe/study_design.owl">
    <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#Ontology"/>
    <vitro:ontologyPrefixAnnot rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ocresd</vitro:ontologyPrefixAnnot>
    <rdfs:label xml:lang="en-US">OCRe study design</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.org/net/OCRe/study_design.owl#Phase_3">
    <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#Class"/>
    <rdfs:subClassOf rdf:resource="http://purl.org/net/OCRe/study_design.owl#OCRE100038"/>
    <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A Phase III trial compares the new treatment against standard (or placebo) treatment (usually a full
randomised controlled trial). At this point, a drug can be approved for community use. [Glossary of Terms in The Cochrane Collaboration]</obo:IAO_0000115>
    <statistics:curator rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Simona</statistics:curator>
    <rdfs:label xml:lang="en-US">Phase 3</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.org/net/OCRe/study_design.owl#Phase_4">
    <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#Class"/>
    <rdfs:subClassOf rdf:resource="http://purl.org/net/OCRe/study_design.owl#OCRE100038"/>
    <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A Phase IV study monitors a new treatment in the community, often to evaluate longterm safety and effectiveness. [Glossary of Terms in The Cochrane Collaboration]</obo:IAO_0000115>
    <statistics:curator rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Simona</statistics:curator>
    <rdfs:label xml:lang="en-US">Phase 4</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.org/net/OCRe/study_design.owl#OCRE100038">
    <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#Class"/>
    <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/BFO_0000015"/>
    <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Phase describes the level of a trial required of drugs before (and after) they are routinely used in clinical practice: 
- Phase I trials assess toxic effects on humans (not many people participate in them, and usually without controls); 
- Phase ll trials assess therapeutic benefit (usually involving a few hundred people, usually with controls, but not always); 
- Phase III trials compare the new treatment against standard (or placebo) treatment (usually a full randomised controlled trial). At this point, a drug can be approved for community use. 
- Phase IV monitors a new treatment in the community, often to evaluate longterm safety and effectiveness. [Glossary of Terms in The Cochrane Collaboration]

A trial can be of a combination phase (e.g., I/II).
The concept of phase is not applicable to trials studying certain interventions (e.g., device, procedure, behavioral)</obo:IAO_0000115>
    <obo:IAO_0000117 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Simona</obo:IAO_0000117>
    <rdfs:label xml:lang="en-US">Phase</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.org/net/OCRe/study_design.owl#Phase_2">
    <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#Class"/>
    <rdfs:subClassOf rdf:resource="http://purl.org/net/OCRe/study_design.owl#OCRE100038"/>
    <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A Phase ll trial assesses therapeutic benefit (usually involving a few hundred people, usually with controls, but not always) [Glossary of Terms in The Cochrane Collaboration]</obo:IAO_0000115>
    <statistics:curator rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Simona</statistics:curator>
    <rdfs:label xml:lang="en-US">Phase 2</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.org/net/OCRe/study_design.owl#Phase_0">
    <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#Class"/>
    <rdfs:subClassOf rdf:resource="http://purl.org/net/OCRe/study_design.owl#OCRE100038"/>
    <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A Phase 0 trial is an exploratory trial involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening study, microdose study). [http://prsinfo.clinicaltrials.gov/definitions.html]</obo:IAO_0000115>
    <statistics:curator rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Simona</statistics:curator>
    <rdfs:label xml:lang="en-US">Phase 0</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.org/net/OCRe/study_design.owl#Single_group_study">
    <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#Class"/>
    <rdfs:subClassOf rdf:resource="http://purl.org/net/OCRe/research.owl#Interventional_study"/>
    <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A single group study is an interventional study that has only a single allocation group and no contemporaneuos comparison group.
A study in which an individual acts has his/her own comparison does not fall into this category, since an individual is not a group.</obo:IAO_0000115>
    <statistics:curator rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Simona</statistics:curator>
    <study_protocol:develop_comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Simona: to be reviewed</study_protocol:develop_comment>
    <rdfs:label xml:lang="en-US">Single Group Study</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.org/net/OCRe/study_design.owl#Phase_1">
    <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#Class"/>
    <rdfs:subClassOf rdf:resource="http://purl.org/net/OCRe/study_design.owl#OCRE100038"/>
    <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A Phase I trial assesses toxic effects on humans (not many people participate, and usually without controls) [Glossary of Terms in The Cochrane Collaboration]</obo:IAO_0000115>
    <statistics:curator rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Simona</statistics:curator>
    <rdfs:label xml:lang="en-US">Phase 1</rdfs:label>
  </rdf:Description>
</rdf:RDF>
